 | |
| Company type | Public |
|---|---|
| Industry | Pharmaceuticals |
| Founded | 1952 |
| Founder | Ramanbhai Patel |
| Headquarters | Ahmedabad, Gujarat, India |
Key people | Pankaj R. Patel (Chairman) Sharvil P. Patel (Managing Director) |
| Products | |
| Revenue |  ₹19,547 crore (US$2.3 billion) (FY24)[1] |
| ₹5,384 crore (US$650 million) (FY24)[1] | |
| ₹3,873 crore (US$460 million) (FY24)[1] | |
Number of employees | 25,000+ (2023) |
| Subsidiaries | Zydus Wellness (57.59%)[2] |
| Website | www |
Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited,[3] is an Indian multinational pharmaceutical company headquartered in Ahmedabad, which is primarily engaged in the manufacturing of generic drugs.[4][5][6] The company ranked 100th in the Fortune India 500 list in 2020.[7]
- ^ a b c "Earnings Presentation: Q4 and Full Year FY24" (PDF). BSE. Zydus Lifesciences Ltd. Retrieved 29 May 2024.
- ^ "Cadila Healthcare Limited". CRISIL. Retrieved 31 January 2023.
- ^ Umarji, Vinay (24 February 2022). "Cadila Healthcare changes name to Zydus Lifesciences Limited". Business Standard India. Retrieved 17 March 2022.
- ^ "Zydus launches SoviHep - the breakthrough therapy for Hepatitis C in alliance with Gilead Sciences". The Hindu Business Line. 17 March 2015. Retrieved 29 December 2017.
- ^ "A Complete Overview on Cadila Healthcare, a growing and popular company in India". business.mapsofindia.com. 21 June 2011. Retrieved 4 February 2009.
- ^ "Cadila Healthcare Profit and Loss Reports - The Economic Times". economictimes.indiatimes.com. Retrieved 15 June 2020.
- ^ "Cadila Healthcare - Fortune 500 List 2020 - Fortune India". www.fortuneindia.com. Retrieved 12 January 2021.